The US Patent and Trademark Office told a group of specialized patent judges on Tuesday afternoon they could be expected to ...

ROCKAWAY, N.J. - electroCore, Inc. (NASDAQ:ECOR), a bioelectronic medicine company with a market capitalization of ...

Some teleworking patent examiners at the US Patent and Trademark Office have less than a week to return to agency offices in ...

A recent filing at the U.S Patent and Trademark Office suggests that Apple is making significant improvements to its AirPods ...

The US Patent and Trademark Office (USPTO) has granted a patent to Vistagen’s non-opioid oral product candidate, AV-101 for ...

While 118 biologics are expected to lose patent protection in the US over the next decade, that $234 billion opportunity for ...

Myriad Genetics announces USPTO grants two new patents for its molecular residual disease assay: Salt Lake City Friday, February 7, 2025, 13:00 Hrs [IST] Myriad Genetics, Inc., a ...

Actimed Therapeutics’ anti-catabolic and pro-anabolic transforming agent, S-pindolol benzoate receives US & European patents: London, UK Friday, February 7, 2025, 16:00 Hrs [IST ...

AstraZeneca is asking a court to immediately stop generic drugmakers from their plans to make and sell generic forms of ...

The Namodenoson oral drug is well positioned in the field of anti-obesity agents due to its activity and favorable safety profile Ramat Gan, ...

The US Patent and Trademark Office (USPTO) has issued new guidance on how inventorship is to be analyzed for inventions ...

The patent application No. 17/309,952 entitled “An A3 adenosine receptor ligand for use for achieving a fat loss effect”, has been accepted by the US Patent Office, will be issued on February ...